Tutti Cancer Warriors
Medical illustration for the Ovarian Cancer guide
Back to library

Ovarian Cancer

Cancer starting in ovaries or fallopian tubes. Often detected late.

The Silent Gynecologic Cancer

Often has no symptoms until it has spread within the pelvis and abdomen. It is the leading cause of death from gynecologic cancers in the Western world.
Medical illustration accompanying the Ovarian Cancer overview

Symptoms (Subtle but Persistent)

  • Persistent abdominal bloating or distention.
  • Feeling full quickly when eating or trouble eating.
  • Discomfort or pain in the pelvic or abdominal area.
  • Need to urinate more frequently or urgently.
  • Changes in bowel habits, such as constipation.
  • Persistent fatigue or back pain.

Combined Treatment

Usually involves a combination of aggressive surgery and chemotherapy.

Debulking Surgery

Removal of as much visible tumor as possible from the abdomen.

Platinum-Based Chemotherapy

The standard of care after surgery for most patients.

Sources and medical information

Prepared by Tutti Cancer Warriors

Sources checked: 28 July 2026

This page provides general educational information. It does not replace medical advice, diagnosis or treatment from a qualified healthcare professional. Ovarian epithelial, fallopian tube and primary peritoneal cancers may not cause early signs or symptoms. Contact a healthcare professional about persistent or worsening abdominal or pelvic pain, swelling or pressure, bloating, urinary urgency or frequency, trouble eating or feeling full, constipation or another concerning change. IARC estimates 330,731 new ovarian cancer cases and 203,850 deaths worldwide in 2024. NCI SEER reports 52.0% five-year relative survival in the United States across all stages combined for 2016–2022. This population statistic cannot predict an individual outcome; prognosis and treatment depend on the cancer type, stage, overall health and response to treatment.

Official sources

Key Facts

331KNew ovarian cancer cases globally in 2024 (IARC estimate)
52.0%Five-year relative survival in the US, all stages combined, 2016–2022 (NCI SEER)

Support a Warrior's Wish

Donate Now